Head-to-head comparisons of medication uses, side effects, warnings, and more.
Glipizide (Glucotrol XL) and exenatide (Byetta, Bydureon BCise) are both used to treat Type 2 diabetes, but they have several differences beween them. Glipizide is taken by mouth, usually once or twice daily, and it helps lower blood sugar by telling your pancreas to release more insulin. Exenatide, on the other hand, is an injectable medication. It helps manage your blood sugar by mimicking a hormone that tells your body to release insulin and blocks sugar release from your liver. Glipizide is available as a lower-cost generic, while exenatide is only available as a brand-name medication, making it more expensive. Glipizide can cause low blood sugar and weight gain, whereas exenatide is less likely to cause low blood sugar and might even help with weight loss. Exenatide also has a risk of thyroid cancer and pancreatitis, which are not associated with glipizide.
Glipizide is a sulfonylurea medication used to treat Type 2 diabetes in adults. It lowers blood sugar levels by telling your pancreas to release more insulin. Glipizide is taken by mouth, typically once or twice daily. Some side effects of this medication include dizziness and diarrhea. Taking glipizide can also put you at risk for dangerously low blood sugar, so it's important to take this medication with meals.
Exenatide is an injectable medication used to lower blood sugar in people with type 2 diabetes. It should be used along with an appropriate diet and exercise plan. This medication comes in short-acting (Byetta) and long-acting (Bydureon BCise) versions.
Note: Side effects were reported by people who took glipizide ER (Glucotrol XL) in clinical studies.
Note: These side effects were reported by people taking either exenatide alone or with other diabetes medications. The side effects you experience might differ depending on what other diabetes medications you're taking.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.